HOME >> BIOLOGY >> NEWS
Vanderbilt's John Oates wins clinical research award

John A. Oates Jr., M.D., Thomas F. Frist Sr. Professor of Medicine and professor of Pharmacology at Vanderbilt University Medical Center, received the Sixteenth Annual Award of Excellence in Clinical Research from the General Clinical Research Centers Program April 17.

The award acknowledges outstanding clinical research, supported by the National Center for Research Resources of the National Institutes of Health.

The $5,000 award and certificate was conferred during the General Clinical Research Centers Program Directors meeting in Chicago. At the meeting, Oates delivered a lecture titled "Investigation on the Contribution of Cyclooxygenases to Human Disease."

"Dr. Oates is a legend in Clinical Research. He put Vanderbilt's clinical research on the map, and I was personally excited to propose him for this award, and gratified that others recognized, as we do, his enormous contributions," said Alastair Wood, M.D., associate dean of external affairs at Vanderbilt.

"There are several important features or characteristics of Vanderbilt that nurtured the research that went on here -- the intent of Vanderbilt Pharmacology to include human pharmacology within the scope of the academic mission of the department," Oates said. "Their commitment to it has brought strong basic science to bear on our clinical research. For the investigation of human pharmacology, this has been an ideal setting."

Oates said the Vanderbilt General Clinical Research Center has been recognized as one of the leading GCRC's in the United States, and a great asset to the Medical School.

"The General Clinical Research Center has provided essential resources for our research, initially under the leadership of Elliot Newman, and more recently, David Robertson," Oates said.

"Recently NIH leadership has rediscovered the importance of patient-oriented research and has taken a number of helpful steps to support it," Robertson said. "As attention has focused on the na
'"/>

Contact: Clinton Colmenares
clinton.colmenares@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
19-Apr-2004


Page: 1 2

Related biology news :

1. Researchers at Vanderbilts Free-Electron Laser Center are developing new forms of laser surgery, improved X-ray technology, and better methods for protein identification
2. Matrisian named Vanderbilts first chair of cancer biology
3. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
4. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
5. Innovative ceramic-on-metal hip replacements to undergo clinical trials
6. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
7. Warren Pharmaceuticals publishes results of preclinical evaluation
8. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
9. Scientists characterize new breast tumor subtypes with poor clinical outcomes
10. Uncertainty in clinical tests raises health care costs
11. Germany starts clinical development of a new tuberculosis vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... CHURCH, Va. (PRWEB) , ... July 08, 2020 ... ... The Latest on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July ... may need a comparability study, but what is the most effective way to ...
(Date:7/4/2020)... ... July 03, 2020 , ... Aesthetics Biomedical ... and multiple awards for not only the products and treatments developed, but also ... Vivace® Microneedle RF. All the brands built by ABM have received several honors ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... publication detailing the use of its revolutionary NEXTGENPCR endpoint thermocycler to test ... 16 minutes. The article, titled "Ultra-fast one-step RT-PCR protocol for the detection ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... The ... radiation centers in 16 countries, has reached its 20th anniversary of worldwide use. ... routine use at top universities including University of Pennsylvania, University of Michigan, University ...
(Date:7/18/2020)... ... 2020 , ... “We are thrilled to deliver this new technology to the ... its kind on the market and we were pleased that the IFT jury recognized ... cultured ingredients, creating a natural way to extend the shelf life and improve the ...
(Date:7/10/2020)... , ... July 09, 2020 ... ... company, announced today that Massachusetts Institute of Technology (MIT) has expanded the ... license allows PathSensors to move into the point-of-care diagnostic market, focusing initially ...
(Date:7/7/2020)... ... 06, 2020 , ... Bio-IT World has announced the winners ... the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance ... highlighting outstanding examples of how technology innovations and strategic initiatives can be powerful ...
Breaking Biology Technology:
Cached News: